Orthocell Co-Founder Professor Minghao Zheng Appointed Member of the Order of Australia (AM)
Orthocell proudly congratulates our Co-Founder and Chief Scientific Officer, Professor Minghao Zheng AM, on being appointed a Member of the Order of Australia (AM).
The West Australian | Biotech’s easy cell to crack American market
An article in The West Australian has highlighted Orthocell’s rapid progress in securing 12 US distributors across 21 states for our flagship nerve repair product Remplir™.
MEDIA | 7 News
Orthocell’s recent FDA clearance made headlines on 7 News this week, with journalist Alice Murray showcasing the human impact of our nerve repair technology.
MEDIA | 9 News
Orthocell welcomed 9 News journalist Michael Stamp to Orthocell HQ last week to film an in-depth segment about our FDA clearance for the nightly news.
Stockhead | Orthocell soars 14% after crushing early sales growth for Remplir
Orthocell’s plans to broaden its commercial footprint in existing and new markets drove the company’s share price up 13.8% this week, according to a special report in Stockhead.
Podcast | Frazis Capital Podcast
Orthocell CEO & MD, Paul Anderson, recently joined Micahel Frazis on the Frazis Capital Podcast.